颈部透明层增厚胎儿的染色体微阵列分析拷贝数变异研究
本研究纳入2015年1月至2017年6月在中山大学附属第一医院行妊娠早期超声筛查的101例NT≥2.5 mm单胎胎儿,行染色体核型分析和CMA检测。结果显示核型异常率31.7%(32/101),单纯组与合并异常组分别为20.6%和54.5%(P<0.01);核型正常的69例中CMA再检出3例(4.3%)致病性CNV,NT值均>3.0 mm。
要点
- NT≥2.5 mm胎儿核型异常率31.7%,合并其他超声异常组高于单纯组(54.5% vs 20.6%,P<0.01)。
- 核型正常的NT增厚胎儿中CMA检出致病性CNV 3例(4.3%,3/69),NT值均>3.0 mm。
- 随NT值增加染色体异常发生率升高,2.5~2.9 mm组与≥5.5 mm组比较差异有统计学意义(P=0.005)。
核心结论
- 高龄孕妇临界性NT增厚(2.5~2.9 mm)胎儿合并染色体核型异常风险增高,但CMA未检出核型正常的临界性NT增厚胎儿中的致病性CNV。
- CMA仅在核型分析正常的NT增厚(≥3.0 mm)胎儿中可进一步检出染色体微缺失和(或)微重复,但检出率相对较低,同时也可检出临床意义不明的CNV。
研究设计与样本
- 回顾性分析2015年1月至2017年6月在中山大学附属第一医院行妊娠早期(11周~13周+6)超声筛查的19 261例单胎胎儿中,超声提示NT≥2.5 mm且接受染色体核型分析及CMA检测的101例(0.5%,101/19 261)。
- 按是否合并其他超声异常分为单纯组68例(67.3%)和合并其他异常组33例(32.7%)。
- 按NT值分为5组:2.5~2.9 mm组17例(16.8%)、3.0~3.4 mm组34例(33.7%)、3.5~4.4 mm组17例(16.8%)、4.5~5.4 mm组16例(15.8%)、≥5.5 mm组17例(16.8%)。
- 不同NT值组间合并其他超声异常及染色体异常发生率比较采用χ2检验。
主要发现
- 101例胎儿中位NT值3.4 mm(范围2.5~8.5 mm)。
- 32例(31.7%,32/101)胎儿染色体核型异常,单纯组与合并异常组核型异常率分别为20.6%(14/68)和54.5%(18/33),差异有统计学意义(P<0.01)。
- 69例(68.3%,69/101)核型正常胎儿中,CMA再检出3例(4.3%,3/69)致病性CNV,其NT值均>3.0 mm。
- 染色体异常(含核型异常及致病性CNV)35例中,单纯组16例(23.5%,16/68),合并异常组19例(57.6%,19/33),两组比较差异有统计学意义(P=0.001)。
- 5组孕妇中位年龄分别为35岁(24~39岁)、33岁(23~46岁)、31岁(21~46岁)、33岁(21~41岁)、35岁(21~43岁);随NT值增加染色体异常发生率逐渐升高,5组比较差异有统计学意义(P<0.05);两两比较仅2.5~2.9 mm组与≥5.5 mm组差异有统计学意义(P=0.005),余组间差异均无统计学意义(P均>0.05)。
临床怎么用
- 作者认为高龄孕妇临界性NT增厚(2.5~2.9 mm)胎儿合并染色体核型异常风险增高。
- 作者认为CMA仅在核型分析正常的NT增厚(≥3.0 mm)胎儿中可进一步检出染色体微缺失和(或)微重复,但检出率相对较低,同时也可检出临床意义不明的CNV。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigated the clinical value of chromosomal microarray analysis (CMA) in fetuses with increased nuchal translucency (NT) . Methods: Totally 101 cases out of 19 261 singleton fetuses who underwent the first trimester (11-13+6 weeks) ultrasound examination from January 2015 to June 2017 at First Affiliated Hospital of Sun Yat-sen University were diagnosed with NT ≥2.5 mm and underwent invasive prenatal test for fetal karyotype and CMA. According to the combination of other ultrasound abnormalities, the cases were divided into isolated group (67.3%, 68/101) and complicated group (32.7%, 33/101) . In addition, the cases were divided into 5 groups according to the thickness of NT, 2.5-2.9 mm (borderline thickening; 16.8%, 17/101) , 3.0-3.4 mm (33.7%, 34/101) , 3.5-4.4 mm (16.8%, 17/101) , 4.5-5.4 mm (15.8%, 16/101) , and ≥5.5 mm (16.8%, 17/101) . Chi square test was used to detect the different rates of other combined ultrasound abnormalities and abnormal chromosome between 5 groups. Results: The median thickness of NT was 3.4 mm (2.5-8.5 mm) . And 32 cases (31.7%, 32/101) had abnormal karyotype. There was a significant difference in the frequency of abnormal karyotype between the isolated and the complicated group (20.6% vs 54.5%, P<0.01) . Among 69 cases (68.3%, 69/101) of normal karyotype, 3 cases (4.3%, 3/69) were detected with pathogenic copy number variation (CNV) by CMA. Thirty-five cases with chromosomal abnormalities (include abnormal karyotype and pathogenic CNV) , there was a significant difference in the frequency of chromosomal abnormalities between the isolated and the complicated group (23.5% vs 57.6%, P=0.001) . The median age of pregnant women in 5 groups was 35 years (24-39 years) , 33 years (23-46 years) , 31 years (21-46 years) , 33 years (21-41 years) and 35 years (21-43 years) . The rates of chromosomal abnormalities increased with the increase of NT thickness. There was significant difference in the incidence of associated chromosomal abnormalities among 5 groups (P<0.05) . Comparative analysis within the 5 groups, the incidence of associated chromosomal abnormalities between NT 2.5-2.9 mm and ≥5.5 mm was significantly different (P=0.005) , while the differences between the other groups were not significant (P>0.05) . Conclusions: There is a high risk of fetal chromosomal abnormalities in borderline NT thickening (2.5-2.9 mm) at advanced maternal age, but the pathogenic CNV is not detected. Chromosomal microdeletion or microduplication could be further detected in the NT thickening (≥3.0 mm) fetuses with normal karyotype by chromosome microarray analysis, while the positive rate is relatively low, and the variants of unknown significance might be detected. 目的: 探讨染色体微阵列分析(CMA)技术检测颈部透明层(NT)增厚胎儿拷贝数变异(CNV)的临床价值。 方法: 2015年1月至2017年6月在中山大学附属第一医院行妊娠早期(11周~13周+6)超声筛查的胎儿共19 261例,其中超声提示NT≥2.5 mm且接受染色体核型分析及CMA检测的单胎胎儿101例(0.5%,101/19 261)。最终纳入研究的101例胎儿,(1)根据是否合并其他超声异常,分为单纯组68例(67.3%)和合并其他异常组33例(32.7%);(2)根据NT值分为5组,2.5~2.9 mm组(即临界性增厚)17例(16.8%),3.0~3.4 mm组34例(33.7%),3.5~4.4 mm组17例(16.8%),4.5~5.4 mm组16例(15.8%),≥5.5 mm组17例(16.8%)。不同NT值组胎儿间合并其他超声异常及染色体异常的发生率比较采用χ2检验。 结果: (1)101例胎儿的中位NT值为3.4 mm(范围:2.5~8.5 mm)。(2)产前诊断结果:共32例(31.7%,32/101)胎儿的染色体核型异常,单纯组与合并异常组胎儿的染色体核型异常的发生率[分别为20.6%(14/68)、54.5%(18/33)]比较,差异有统计学意义(P<0.01)。69例(68.3%,69/101)染色体核型正常的胎儿中,CMA再检出3例(4.3%,3/69)含有致病性CNV,其NT值均>3.0 mm。染色体异常的35例胎儿中(包含核型异常及致病性CNV),16例(23.5%,16/68)为单纯组,19例(57.6%,19/33)为合并异常组,两组胎儿染色体异常的检出率比较,差异有统计学意义(P=0.001)。(3)不同NT值组胎儿:胎儿NT值为2.5~2.9 mm组、3.0~3.4 mm组、3.5~4.4 mm组、4.5~5.4 mm组、≥5.5 mm组孕妇的中位年龄分别为35岁(24~39岁)、33岁(23~46岁)、31岁(21~46岁)、33岁(21~41岁)、35岁(21~43岁)。随NT值的增加,胎儿合并染色体异常的发生率逐渐升高,5组胎儿染色体异常的检出率比较,差异有统计学意义(P<0.05);两两比较,2.5~2.9 mm组与≥5.5 mm组胎儿染色体异常的发生率比较,差异有统计学意义(P=0.005),余组间比较,差异均无统计学意义(P均>0.05)。 结论: 母亲为高龄孕妇时,临界性NT增厚胎儿合并染色体核型异常的风险增高,但CMA未检出染色体核型正常的临界性NT增厚胎儿中的致病性CNV。CMA仅在染色体核型分析正常的NT增厚(NT≥3.0 mm)胎儿中可进一步检出染色体微缺失和(或)微重复,但检出率相对较低,同时也可检出临床意义不明的CNV。.
引用
- Du L, Xie HN, Zheng J, et al. [Analysis of copy number variation by CMA in fetus with increased nuchal translucency]. Zhonghua Fu Chan Ke Za Zhi. 2018. PMID: 30369122. doi:10.3760/cma.j.issn.0529-567x.2018.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。